Atlas Trials

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma

Clinical trial NCT01944709 · TERMINATED

Trial details

NCT number
NCT01944709
Sponsor
Prof. Dr. Silke Gillessen
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2006-08-01
Primary completion
2007-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.